Published in Drug Week, November 15th, 2002
"We found that cholinesterase inhibitors will benefit patients with Alzheimer's disease or vascular dementia, or mixed cases involving both Alzheimer's and vascular causes. This provides further support for treating patients with these drugs...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.